Myriad Genetics, Inc. (MYGN) NASDAQ
4.28
+0.31(+7.81%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.28
+0.31(+7.81%)
Currency In USD
| Market Cap | 573.79M |
| Enterprise Value | 634M |
| P/E Ratio | -1 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.49 |
| Price/Book Ratio | 1.19 |
| Enterprise/Revenue | 0.59 |
| Enterprise/EBITDA | -1.47 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.48 |
| Operating Margin | -0.46 |
| Return On Assets | -0.59 |
| Return On Equity | -1.09 |
| Revenue | 824.5M |
| Revenue/Share | 8.85 |
| Gross Profit | 576.6M |
| EBITDA | -330.9M |
| Net Income | -365.9M |
| Diluted EPS | -3.96 |
| Total Cash | 124.4M |
| Total Cash/Share | 1.33 |
| Total Debt | 211.5M |
| Total Debt/Equity | 0.63 |
| Current Ratio | 2.4 |
| Book Value Per Share | 3.6 |
| 52-Week Change | -4.04 |
| 52-Week High | 8.59 |
| 52-Week Low | 3.53 |
| Moving Average 50 Days | 4.45 |
| Moving Average 200 Days | 5.96 |
| Average Volume | 1.9M |
| Shares Outstanding | 94.45M |
| % Held by Institutions | 228.16 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
| Last Split Date | March 26, 2009 |